Vaccines, blood, antisera, toxins and cultures in United Kingdom

About

Exports In 2023, United Kingdom exported $6.74B in Vaccines, blood, antisera, toxins and cultures, making it the 12th largest exporter of Vaccines, blood, antisera, toxins and cultures in the world. At the same year, Vaccines, blood, antisera, toxins and cultures was the 10th most exported product in United Kingdom. The main destination of Vaccines, blood, antisera, toxins and cultures exports from United Kingdom are: United States ($3.22B), France ($729M), South Korea ($317M), Japan ($287M), and Germany ($273M).

The fastest growing export markets for Vaccines, blood, antisera, toxins and cultures of United Kingdom between 2022 and 2023 were United States ($702M), South Korea ($290M), and France ($227M).

Imports In 2023, United Kingdom imported $8.44B in Vaccines, blood, antisera, toxins and cultures, becoming the 10th largest importer of Vaccines, blood, antisera, toxins and cultures in the world. At the same year, Vaccines, blood, antisera, toxins and cultures was the 13th most imported product in United Kingdom. United Kingdom imports Vaccines, blood, antisera, toxins and cultures primarily from: United States ($1.94B), Switzerland ($1.43B), Belgium ($1.21B), Germany ($1.19B), and Ireland ($909M).

The fastest growing import markets in Vaccines, blood, antisera, toxins and cultures for United Kingdom between 2022 and 2023 were Switzerland ($290M), United States ($248M), and France ($96M).

Latest Trends

November 2024

About

Overview In November 2024 United Kingdom's Vaccines, blood, antisera, toxins and cultures exports accounted up to £470M and imports accounted up to £682M, resulting in a negative trade balance of £212M. Between November 2023 and November 2024 the exports of United Kingdom's Vaccines, blood, antisera, toxins and cultures have decreased by £-201M (-29.9%) from £671M to £470M, while imports increased by £136M (25%) from £546M to £682M.

Destinations In November 2024, Vaccines, blood, antisera, toxins and cultures were exported mostly to United States (£224M), France (£67.4M), Germany (£19.2M), Switzerland (£19.2M), and Netherlands (£14.4M), and were imported mostly from Belgium (£154M), Netherlands (£125M), Switzerland (£95.5M), United States (£77.8M), and Germany (£52.2M).

Growth In November 2024, the decrease in Vaccines, blood, antisera, toxins and cultures's year-by-year exports was explained primarily by a decrease in exports to Russia (£-4.24M or -88.4%), Mexico (£-3.22M or -74.5%), and Sweden (£-2.1M or -53.4%). In November 2024, the increase in Vaccines, blood, antisera, toxins and cultures's year-by-year imports was explained primarily by an increase in imports from Belgium (£82.8M or 182%), Germany (£60.5M or 89.5%), and Netherlands (£33.2M or 57.2%).

Subnational Monthly Trade

Time Scale

Year

Quarter

Month

Flow

Exports

Imports

Color

Trade Value

Growth

Growth (%)

EXPORT GROWTH (November 2023 - November 2024)£-201M(-29.9%)

IMPORT GROWTH (November 2023 - November 2024)£136M(25%)

MAIN EXPORTER (November 2024)London Heathrow Airport£349M

MAIN DESTINATION (November 2024)United States£224M

This section shows Vaccines, blood, antisera, toxins and cultures's exports and imports data at subnational level for United Kingdom. Click any date in the line plot, any subnational region in the geomap, or any destination or origin country to explore the exports or imports behavior of Vaccines, blood, antisera, toxins and cultures over time.

For full datasets download visit Bulk Download page.

Go to Bulk Download